HEADER MEMBRANE PROTEIN 09-AUG-00 1FKC TITLE HUMAN PRION PROTEIN (MUTANT E200K) FRAGMENT 90-231 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PRION PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PRP(90-231); COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BRAIN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET3; SOURCE 10 OTHER_DETAILS: BRAIN KEYWDS THREE HELIX, CREUTZFELDT-JAKOB DISEASE, PRION, AGGREGATION, MEMBRANE KEYWDS 2 PROTEIN EXPDTA SOLUTION NMR AUTHOR Y.ZHANG,W.SWIETNICKI,M.G.ZAGORSKI,W.K.SUREWICZ,F.D.SOENNICHSEN REVDAT 6 14-MAR-18 1FKC 1 REMARK SEQADV REVDAT 5 24-FEB-09 1FKC 1 VERSN REVDAT 4 01-APR-03 1FKC 1 JRNL REVDAT 3 25-APR-01 1FKC 1 KEYWDS AUTHOR JRNL REVDAT 2 22-SEP-00 1FKC 3 AUTHOR JRNL ATOM REVDAT 1 21-SEP-00 1FKC 0 JRNL AUTH Y.ZHANG,W.SWIETNICKI,M.G.ZAGORSKI,W.K.SUREWICZ, JRNL AUTH 2 F.D.SONNICHSEN JRNL TITL SOLUTION STRUCTURE OF THE E200K VARIANT OF HUMAN PRION JRNL TITL 2 PROTEIN. IMPLICATIONS FOR THE MECHANISM OF PATHOGENESIS IN JRNL TITL 3 FAMILIAL PRION DISEASES. JRNL REF J.BIOL.CHEM. V. 275 33650 2000 JRNL REFN ISSN 0021-9258 JRNL PMID 10954699 JRNL DOI 10.1074/JBC.C000483200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9, CNS 0.9 REMARK 3 AUTHORS : BRUNGER (CNS), BRUNGER (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1FKC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-SEP-00. REMARK 100 THE DEPOSITION ID IS D_1000011668. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 299 REMARK 210 PH : 4.6 REMARK 210 IONIC STRENGTH : 0.00001 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.8 MM E200K(90-231)PRP U REMARK 210 -15N,13C; 10MM ACETATE BUFFER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY; 3D_15N REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX; INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA 0.9 REMARK 210 METHOD USED : SIMULATED ANNEALING MOLECULAR REMARK 210 DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 60 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 11 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR REMARK 210 SPECTROSCOPY. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 RES C SSSEQI REMARK 465 GLY A 90 REMARK 465 GLN A 91 REMARK 465 GLY A 92 REMARK 465 GLY A 93 REMARK 465 GLY A 94 REMARK 465 THR A 95 REMARK 465 HIS A 96 REMARK 465 SER A 97 REMARK 465 GLN A 98 REMARK 465 TRP A 99 REMARK 465 ASN A 100 REMARK 465 LYS A 101 REMARK 465 PRO A 102 REMARK 465 SER A 103 REMARK 465 LYS A 104 REMARK 465 PRO A 105 REMARK 465 LYS A 106 REMARK 465 THR A 107 REMARK 465 ASN A 108 REMARK 465 MET A 109 REMARK 465 LYS A 110 REMARK 465 HIS A 111 REMARK 465 MET A 112 REMARK 465 ALA A 113 REMARK 465 GLY A 114 REMARK 465 ALA A 115 REMARK 465 ALA A 116 REMARK 465 ALA A 117 REMARK 465 ALA A 118 REMARK 465 GLY A 119 REMARK 465 ALA A 120 REMARK 465 VAL A 121 REMARK 465 VAL A 122 REMARK 465 GLY A 123 REMARK 465 GLY A 124 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 132 172.00 -52.92 REMARK 500 MET A 134 -71.03 -130.63 REMARK 500 PHE A 141 -93.00 -99.71 REMARK 500 SER A 143 -154.30 -148.65 REMARK 500 ASP A 167 -157.65 -105.55 REMARK 500 TYR A 169 74.06 55.24 REMARK 500 REMARK 500 REMARK: NULL DBREF 1FKC A 90 231 UNP P04156 PRIO_HUMAN 90 231 SEQADV 1FKC LYS A 200 UNP P04156 GLU 200 ENGINEERED MUTATION SEQRES 1 A 142 GLY GLN GLY GLY GLY THR HIS SER GLN TRP ASN LYS PRO SEQRES 2 A 142 SER LYS PRO LYS THR ASN MET LYS HIS MET ALA GLY ALA SEQRES 3 A 142 ALA ALA ALA GLY ALA VAL VAL GLY GLY LEU GLY GLY TYR SEQRES 4 A 142 MET LEU GLY SER ALA MET SER ARG PRO ILE ILE HIS PHE SEQRES 5 A 142 GLY SER ASP TYR GLU ASP ARG TYR TYR ARG GLU ASN MET SEQRES 6 A 142 HIS ARG TYR PRO ASN GLN VAL TYR TYR ARG PRO MET ASP SEQRES 7 A 142 GLU TYR SER ASN GLN ASN ASN PHE VAL HIS ASP CYS VAL SEQRES 8 A 142 ASN ILE THR ILE LYS GLN HIS THR VAL THR THR THR THR SEQRES 9 A 142 LYS GLY GLU ASN PHE THR LYS THR ASP VAL LYS MET MET SEQRES 10 A 142 GLU ARG VAL VAL GLU GLN MET CYS ILE THR GLN TYR GLU SEQRES 11 A 142 ARG GLU SER GLN ALA TYR TYR GLN ARG GLY SER SER HELIX 1 1 SER A 143 MET A 154 1 12 HELIX 2 2 HIS A 155 TYR A 157 5 3 HELIX 3 3 ASN A 171 GLY A 195 1 25 HELIX 4 4 THR A 199 GLY A 229 1 31 SHEET 1 A 2 MET A 129 GLY A 131 0 SHEET 2 A 2 VAL A 161 TYR A 163 -1 O VAL A 161 N GLY A 131 SSBOND 1 CYS A 179 CYS A 214 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000